Surgi-ORC®: Real-World Solutions for Safer ENT Procedures

Surgi-ORC®: Real-World Solutions for Safer ENT Procedures

 

The ear, nose and throat (ENT) area is delicate and richly supplied with blood vessels and nerves, making even minor surgeries prone to bleeding and complications. Procedures such as posterior turbinectomy, medial maxillectomy, nasal neurotomy, gland excisions, adenoidectomy, tonsillectomy, and endoscopic sinus surgery carry particularly high bleeding risks.1–4

Traditional hemostatic methods, such as electrocautery, are commonly used in otolaryngology (ENT) but carry several risks2:

  • Risk of burns from improper placement
  • Conductive pathways created by blood or sweat, increasing burn risk
  • Pressure injuries and skin folds from incorrect patient positioning
  • Inconsistent results in tight or anatomically complex spaces

These limitations highlight the need for safer and more adaptable topical haemostats. To address this, Surgi-ORC®, offers a safe and cost-effective solution for achieving reliable haemostasis during otorhinolaryngological surgeries.

What is Surgi-ORC®?

Surgi-ORC® is a natural, plant-based absorbable haemostat made from oxidized regenerated cellulose (ORC). It is designed to fix the shortcomings of traditional ORC materials and is biocompatible, fast-acting, bactericidal, easily cut, flexible, suturable, and usable dry around bleeding sites.

Surgi-ORC® Variants for ENT Procedures:

Surgi-ORC® is available in Knit, Original/Standard, and Powder forms to meet diverse procedural needs.

Press enter or click to view image in full size
Fig 1: Surgi-ORC® Absorbable Haemostat (Oxidized Regenerated Cellulose)
Press enter or click to view image in full size
Press enter or click to view image in full size

Clinical Evidence

The study evaluated Surgi-ORC® Knit in four ENT surgeries: Parotidectomy, Thyroidectomy, Neck mass excision and Submandibular gland excision. All cases experienced moderate intraoperative bleeding with Surgi-ORC® applied directly to the bleeding site for effective control. On follow-up day 60, no of infections, adhesions, granuloma formation, or foreign body reactions were observed.3

CT Scan Findings3:

Day of application: Surgi-ORC® material visible at the operated sinus site
Day 2: Material complete absorbed/degraded

Press enter or click to view image in full size
Fig 2: CT scan image: A) Left panel (day of application): Surgi-ORC material (Indicated by arrows) is visible in the operated sinus cavity immediately after application. B) Right panel (day 2): the same region shows no visible Surgi-ORC material, indicating its absorption/degradation within two days.3

Key Findings:3

  • Time to Haemostasis: 0.93–2.1 minutes
  • Absorption: Complete in all cases by Day 28
  • Adverse events /Complications: None observed
  • Surgeon feedback: Rated “good” to “excellent” for handling

Conclusion:

  • Surgi-ORC® provides a practical, effective and safe approach to bleeding control in ENT surgery. Early real-world experience positions it as a valuable tool for surgeons seeking reliable haemostasis and smoother operative results.

Comments

Popular posts from this blog

Revolutionizing Surgical Hemostasis: Introducing Surgi-ORC® Powder (Absorbable Hemostatic Powder)

Comprehensive Health Check-Up: A Commitment to Employee Well-Being

Role of Surgi-ORC® Fibril and SURGISPON® in Posterior Fossa Tumor Resections